|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3687513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18788905.0 |
| Date of filing the European patent application | 2018-09-27 | |
| (97) | Date of publication of the European application | 2020-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-15 |
| (46) | Date of publication of the claims translation | 2022-03-10 |
| (86) | Number | PCT/IB2018/057519 |
| Date | 2018-09-27 |
| (87) | Number | WO 2019/064234 |
| Date | 2019-04-04 |
| (30) | Number | Date | Country code |
| 201762564834 P | 2017-09-28 | US | |
| 201862632532 P | 2018-02-20 | US |
| (72) |
BONN-MILLER, Marcel , US
TICH, Nancy , US
GUTTERMAN, Donna , US
MESSENHEIMER, John , US
SEBREE, Terri , US
|
| (73) |
Harmony Biosciences Management, Inc.,
630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Trapiosios X chromosomos sindromo ir autizmo gydymas kanabidioliu |
| TREATMENT OF FRAGILE X SYNDROME AND AUTISM WITH CANNABIDIOL |
| Payment date | Validity (years) | Amount | |
| 2025-09-03 | 8 | 185.00 EUR |
| 2026-09-27 |